693. Clinical and Economic Outcomes Associated with Fidaxomicin in Comparison to Vancomycin, Metronidazole, and FMT: a Systematic Literature Review

BACKGROUND: Clostridioides difficile causes Clostridioides difficile infection (CDI), of which there are estimated half a million cases in the United States (US) each year. Fidaxomicin, vancomycin, and metronidazole are commonly used for the treatment of CDI, and fidaxomicin is recommended by clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qinghua, Obi, Engels N, Marciniak, Anne, Newman, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679099/
http://dx.doi.org/10.1093/ofid/ofad500.755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679099/
http://dx.doi.org/10.1093/ofid/ofad500.755

Ejemplares similares